A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

被引:139
作者
Smith, SR [1 ]
Bai, FL [1 ]
Charbonneau, C [1 ]
Janderová, L [1 ]
Argyropoulos, G [1 ]
机构
[1] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
D O I
10.2337/diabetes.52.7.1611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a component of type 2 diabetes and often precedes pancreatic beta-cell failure. Contributing factors include obesity and a central pattern of fat accumulation with a strong genetic component. The adipocyte secreted hormone resistin has been proposed as a link between the adipocyte and insulin resistance by inhibition of insulin-stimulated glucose uptake and/or blocking adipocyte differentiation. Here we report that the G/G genotype of a single nucleotide polymorphism (SNP) in the promoter of the human resistin gene, -180C>G, had significantly increased basal promoter activity in adipocytes. These data were recapitulated in vivo, where G/G homozygotes had significantly higher resistin mRNA levels in human abdominal subcutaneous fat. A significant interaction was also found between the -180C>G SNP, a marker of oxidative stress (NAD[P]H quinone oxidoreductase mRNA) and homeostasis model assessment of insulin resistance. In addition, resistin mRNA was positively and independently correlated with insulin resistance and hepatic fat as measured by liver X-ray attenuation. These data implicate resistin in the pathophysiology of the human insulin resistance syndrome, an effect mediated by the -180C>G promoter SNP and potentially cellular oxidative stress.
引用
收藏
页码:1611 / 1618
页数:8
相关论文
共 41 条
[21]   Insulin resistance and Type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle [J].
Nagaev, I ;
Smith, U .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (02) :561-564
[22]   Systematic search for single nucleotide polymorphisms in the resistin gene - The absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes [J].
Osawa, H ;
Onuma, H ;
Murakami, A ;
Ochi, M ;
Nishimiya, T ;
Kato, K ;
Shimizu, I ;
Fujii, Y ;
Ohashi, J ;
Makino, H .
DIABETES, 2002, 51 (03) :863-866
[23]   An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance [J].
Pizzuti, A ;
Argiolas, A ;
Di Paola, R ;
Baratta, R ;
Rauseo, A ;
Bozzali, M ;
Vigneri, R ;
Dallapiccola, B ;
Trischitta, V ;
Frittitta, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4403-4406
[24]   Control of oxygen free radical formation from mitochondrial complex I: Roles for protein kinase A and pyruvate dehydrogenase kinase [J].
Raha, S ;
Myint, AT ;
Johnstone, L ;
Robinson, BH .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (05) :421-430
[25]   Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue [J].
Rajala, MW ;
Lin, Y ;
Ranalletta, M ;
Yang, XM ;
Qian, H ;
Gingerich, R ;
Barzilai, N ;
Scherer, PE .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (08) :1920-1930
[26]   Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes [J].
Rudich, A ;
Kozlovsky, N ;
Potashnik, R ;
Bashan, N .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (05) :E935-E940
[27]   Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes [J].
Rudich, A ;
Tirosh, A ;
Potashnik, R ;
Khamaisi, M ;
Bashan, N .
DIABETOLOGIA, 1999, 42 (08) :949-957
[28]   Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients [J].
Ryysy, L ;
Häkkinen, AM ;
Goto, T ;
Vehkavaara, S ;
Westerbacka, J ;
Halavaara, J ;
Yki-Järvinen, H .
DIABETES, 2000, 49 (05) :749-758
[29]   Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans [J].
Savage, DB ;
Sewter, CP ;
Klenk, ES ;
Segal, DG ;
Vidal-Puig, A ;
Considine, RV ;
O'Rahilly, S .
DIABETES, 2001, 50 (10) :2199-2202
[30]  
SCHUG J, CBILTR19971001V00 U